Eribulin Mesylate in Treating Patients With Recurrent Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer
Clinical trial NCT00334893 · COMPLETED
Trial details
- NCT number
- NCT00334893
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-04-01
- Primary completion
- 2012-03-01
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.